# Metformin and Lactoferrin in Sepsis in Icu

> **NCT06181422** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Tanta University** · enrollment: 60 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Metformin
- **DRUG:** Lactoferrin

## Key facts

- **NCT ID:** NCT06181422
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2024-06-09
- **Final completion:** 2024-06-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06181422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06181422, "Metformin and Lactoferrin in Sepsis in Icu". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06181422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*